Literature DB >> 10709865

VPF/VEGF and the angiogenic response.

H F Dvorak1.   

Abstract

Vasculogenesis, the generation of new blood vessels de novo, and angiogenesis, the formation of new blood vessels from preexisting vessels, are mediated by a number of cytokines and growth factors among which vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is one of the most important. VPF/VEGF is secreted by many tumor cells, at sites of wound healing and chronic inflammation, and in physiological angiogenesis as in corpus luteum formation. VPF/VEGF is a multifunctional cytokine that interacts with two high affinity tyrosine kinase receptors that are selectively expressed on vascular endothelium. This interaction triggers an angiogenic cascade whose steps, among others, include increased microvascular permeability, leading to deposition of a pro-angiogenic extracellular fibrin matrix, and the formation of mother/daughter vessels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709865     DOI: 10.1016/s0146-0005(00)80061-0

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  34 in total

Review 1.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

3.  GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice.

Authors:  Tim D Eubank; Ryan Roberts; Michelle Galloway; Yijie Wang; David E Cohn; Clay B Marsh
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

4.  Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.

Authors:  Michael H Muders; Heyu Zhang; Enfeng Wang; Donald J Tindall; Kaustubh Datta
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

Review 5.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 6.  Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.

Authors:  D J Brat; E G Van Meir
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 7.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

8.  Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency.

Authors:  Ying Chen; Yang Hu; Gennadiy Moiseyev; Kevin K Zhou; Danyang Chen; Jian-xing Ma
Journal:  Microvasc Res       Date:  2009-03-10       Impact factor: 3.514

9.  Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.

Authors:  Md Ruhul Abid; Robert J Nadeau; Katherine C Spokes; Takashi Minami; Dan Li; Shou-Ching Shih; William C Aird
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-11       Impact factor: 8.311

10.  Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells.

Authors:  Hua Mu; Xiao-Mei Zhang; Jian-Ju Liu; Li Dong; Zhuo-Lei Feng
Journal:  Mol Biol Rep       Date:  2008-12-24       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.